Approval · Notice of Compliance 7838 · 2006
CLAFORAN: Notice of Compliance 7838
Issued March 21, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7838
- Date
- March 21, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- CEFOTAXIME SODIUM 500 MG per VIAL
- CEFOTAXIME SODIUM 1 G per VIAL
- CEFOTAXIME SODIUM 2 G per VIAL